{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:46:49Z","timestamp":1765234009293,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074064"],"award-info":[{"award-number":["82074064"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A151540186"],"award-info":[{"award-number":["2022A151540186"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2021A1515012521"],"award-info":[{"award-number":["2021A1515012521"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004024","name":"Jinan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.cbi.2025.111559","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T18:34:01Z","timestamp":1747506841000},"page":"111559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Acetyl alkannin, a Shikonin monomer, inhibits the ATM\/DDR pathway by targeting ATM and sensitizes cisplatin in solid tumors"],"prefix":"10.1016","volume":"417","author":[{"given":"Xinwen","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zifeng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunqian","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5482-4641","authenticated-orcid":false,"given":"Jianwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2025.111559_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cbi.2025.111559_bib2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2025.111559_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14010080","article-title":"Targeting estrogens and various estrogen-related receptors against non-small cell lung cancers: a perspective","volume":"14","author":"Maitra","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.cbi.2025.111559_bib4","article-title":"Lentinan combined with cisplatin for the treatment of non-small cell lung cancer","volume":"100","author":"Zhao","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.cbi.2025.111559_bib5","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.7150\/ijbs.70958","article-title":"VEGF\/VEGFR-targeted therapy and immunotherapy in non-small cell lung cancer: targeting the tumor microenvironment","volume":"18","author":"Zhao","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cbi.2025.111559_bib6","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s12094-023-03337-9","article-title":"Immunoradiotherapy for NSCLC: mechanisms, clinical outcomes, and future directions","volume":"26","author":"Weishan","year":"2024","journal-title":"Clin. Transl. Oncol. : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico"},{"key":"10.1016\/j.cbi.2025.111559_bib7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jtho.2023.01.091","article-title":"Clinicopathologic and genomic factors impacting efficacy of first-line chemoimmunotherapy in advanced NSCLC","volume":"18","author":"Alessi","year":"2023","journal-title":"J. Thorac. Oncol. : official publication of the International Association for the Study of Lung Cancer"},{"key":"10.1016\/j.cbi.2025.111559_bib8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ccell.2024.04.005","article-title":"Immunotherapy in resectable NSCLC: answering the question or questioning the answer?","volume":"42","author":"Liu","year":"2024","journal-title":"Cancer Cell"},{"issue":"2025","key":"10.1016\/j.cbi.2025.111559_bib9","first-page":"10","article-title":"Cancer statistics","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cbi.2025.111559_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1470-2045(21)00604-5","article-title":"Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial","volume":"23","author":"Yau","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cbi.2025.111559_bib11","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(23)01796-8","article-title":"Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial","volume":"402","author":"Qin","year":"2023","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.cbi.2025.111559_bib12","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.apsb.2022.03.003","article-title":"Concurrent silencing of TBCE and drug delivery to overcome platinum-based resistance in liver cancer","volume":"13","author":"Li","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cbi.2025.111559_bib13","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1021\/cr400460s","article-title":"Metallodrugs in medicinal inorganic chemistry","volume":"114","author":"Mjos","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.cbi.2025.111559_bib14","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.cbi.2025.111559_bib15","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cbi.2025.111559_bib16","doi-asserted-by":"crossref","DOI":"10.6061\/clinics\/2018\/e478s","article-title":"DNA repair pathways and cisplatin resistance: an intimate relationship","volume":"73","author":"Rocha","year":"2018","journal-title":"Clinics"},{"key":"10.1016\/j.cbi.2025.111559_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41568-020-00308-y","article-title":"The rediscovery of platinum-based cancer therapy","volume":"21","author":"Rottenberg","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cbi.2025.111559_bib18","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.4149\/neo_2021_210515N667","article-title":"Expression and prognostic significance of the DNA damage response pathway and autophagy markers in gastric cancer","volume":"68","author":"Xu","year":"2021","journal-title":"Neoplasma"},{"key":"10.1016\/j.cbi.2025.111559_bib19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc2342","article-title":"DNA repair pathways as targets for cancer therapy","volume":"8","author":"Helleday","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cbi.2025.111559_bib20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nature06337","article-title":"Human CtIP promotes DNA end resection","volume":"450","author":"Sartori","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2025.111559_bib21","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016410","article-title":"An overview of the molecular mechanisms of recombinational DNA repair","volume":"7","author":"Kowalczykowski","year":"2015","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.cbi.2025.111559_bib22","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrc.2017.53","article-title":"Targeting autophagy in cancer","volume":"17","author":"Levy","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cbi.2025.111559_bib23","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1158\/2159-8290.CD-19-0292","article-title":"Targeting autophagy in cancer: recent advances and future directions","volume":"9","author":"Amaravadi","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cbi.2025.111559_bib24","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012716","article-title":"DNA damage sensing by the ATM and ATR kinases","volume":"5","author":"Mar\u00e9chal","year":"2013","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.cbi.2025.111559_bib25","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1080\/15384101.2016.1158362","article-title":"Structure of the human dimeric ATM kinase","volume":"15","author":"Lau","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.cbi.2025.111559_bib26","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1159\/000487724","article-title":"CHK2 promotes anoikis and is associated with the progression of papillary thyroid cancer","volume":"45","author":"Zhao","year":"2018","journal-title":"Cell. Physiol. Biochem. : international journal of experimental cellular physiology, biochemistry, and pharmacology"},{"key":"10.1016\/j.cbi.2025.111559_bib27","article-title":"Trial Watch: targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapy","volume":"vol. 2","author":"Manic","year":"2015"},{"key":"10.1016\/j.cbi.2025.111559_bib28","doi-asserted-by":"crossref","first-page":"7347","DOI":"10.1093\/nar\/gks353","article-title":"RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells","volume":"40","author":"Budke","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cbi.2025.111559_bib29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1871520617666170919164055","article-title":"Targeting cell necroptosis and apoptosis induced by shikonin via receptor interacting protein kinases in estrogen receptor positive breast cancer cell line, MCF-7","volume":"18","author":"Shahsavari","year":"2018","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.cbi.2025.111559_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153460","article-title":"Uncovering the antitumor effects and mechanisms of Shikonin against colon cancer on comprehensive analysis","volume":"82","author":"Chen","year":"2021","journal-title":"Phytomedicine : international journal of phytotherapy and phytopharmacology"},{"key":"10.1016\/j.cbi.2025.111559_bib31","article-title":"Effect of shikonin on the proliferation and apoptosis of human ovarian cancer cell SKOV3: a protocol of systematic review and meta-analysis","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.cbi.2025.111559_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104463","article-title":"Pharmacological properties and derivatives of shikonin-A review in recent years","volume":"149","author":"Guo","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2025.111559_bib33","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.apsb.2021.08.025","article-title":"Chemical screen identifies shikonin as a broad DNA damage response inhibitor that enhances chemotherapy through inhibiting ATM and ATR","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cbi.2025.111559_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153805","article-title":"Shikonin, a naphthalene ingredient: therapeutic actions, pharmacokinetics, toxicology, clinical trials and pharmaceutical researches","volume":"94","author":"Sun","year":"2022","journal-title":"Phytomedicine : international journal of phytotherapy and phytopharmacology"},{"key":"10.1016\/j.cbi.2025.111559_bib35","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.cbi.2025.111559_bib36","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/s41467-019-09175-0","article-title":"UFL1 promotes histone H4 ufmylation and ATM activation","volume":"10","author":"Qin","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cbi.2025.111559_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cells8101275","article-title":"Capsaicin targets tNOX (ENOX2) to inhibit G1 cyclin\/CDK complex, as assessed by the cellular thermal shift assay (CETSA)","volume":"8","author":"Islam","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.cbi.2025.111559_bib38","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1158\/1078-0432.CCR-13-3141","article-title":"Molecular pathways: the immunogenic effects of platinum-based chemotherapeutics","volume":"20","author":"Hato","year":"2014","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.cbi.2025.111559_bib39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2217\/14796694.5.1.33","article-title":"New-generation platinum agents for solid tumors","volume":"5","author":"Shah","year":"2009","journal-title":"Future Oncol."},{"key":"10.1016\/j.cbi.2025.111559_bib40","doi-asserted-by":"crossref","first-page":"10524","DOI":"10.1074\/jbc.TM118.000372","article-title":"Homologous recombination and the repair of DNA double-strand breaks","volume":"293","author":"Wright","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2025.111559_bib41","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.canlet.2021.10.001","article-title":"SERPINE2\/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer","volume":"524","author":"Zhang","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2025.111559_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003277","article-title":"The interaction of CtIP and Nbs1 connects CDK and ATM to regulate HR-mediated double-strand break repair","volume":"9","author":"Wang","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.cbi.2025.111559_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15051474","article-title":"A triphenylphosphonium-functionalized delivery system for an ATM kinase inhibitor that ameliorates doxorubicin resistance in breast carcinoma mammospheres","volume":"15","author":"Stagni","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.cbi.2025.111559_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd5750","article-title":"ALT neuroblastoma chemoresistance due to telomere dysfunction-induced ATM activation is reversible with ATM inhibitor AZD0156","volume":"13","author":"Koneru","year":"2021","journal-title":"Sci. Transl. Med."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725001899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725001899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:52:11Z","timestamp":1762113131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279725001899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":44,"alternative-id":["S0009279725001899"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111559","relation":{},"ISSN":["0009-2797"],"issn-type":[{"type":"print","value":"0009-2797"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetyl alkannin, a Shikonin monomer, inhibits the ATM\/DDR pathway by targeting ATM and sensitizes cisplatin in solid tumors","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111559"}}